P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
about
The role of nucleotides and purinergic signaling in apoptotic cell clearance - implications for chronic inflammatory diseases.Bile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.An Update on P2Y13 Receptor Signalling and Function.Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations.
P2860
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
@ast
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
@en
type
label
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
@ast
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
@en
prefLabel
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
@ast
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
@en
P2093
P2860
P1433
P1476
P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo
@en
P2093
Alice Bluteau
Claudine Tardy
Daniela C Oniciu
Guy Cholez
Jean-Louis H Dasseux
Marine Goffinet
Nadia Boubekeur
Narendra D Lalwani
Ronald Barbaras
Rudi Baron
P2860
P304
P356
10.1371/JOURNAL.PONE.0095807
P407
P577
2014-04-25T00:00:00Z